Skip to main content

Practical Management of Dyslipidemia in Stroke Patients

  • Chapter
  • First Online:
Stroke Revisited: Dyslipidemia in Stroke

Part of the book series: Stroke Revisited ((STROREV))

  • 423 Accesses

Abstract

A strategy involving a low target concentration appears to be superior to one involving a moderate circulating LDL-cholesterol (LDL-c) reduction for the prevention of cardio-cerebrovascular disease in patients with coronary disease and in those with carotid artery disease. However, it remains uncertain whether statins are beneficial, and if they are, what would be the most appropriate LDL-c target concentration in stroke patients without carotid artery disease. This chapter will focus on the evidences to elucidate the appropriate strategies in patients with stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Trialists CT. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.

    Article  Google Scholar 

  2. Investigators SPbARiCL. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–59.

    Article  Google Scholar 

  3. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A III, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2007;38(12):3198–204.

    Article  CAS  Google Scholar 

  4. Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382(1):9–19.

    Article  CAS  Google Scholar 

  5. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2008;39(12):3297–302.

    Article  CAS  Google Scholar 

  6. Ebrahim S, Sung J, Song Y-M, Ferrer RL, Lawlor DA, Smith GD. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ. 2006;333(7557):22.

    Article  Google Scholar 

  7. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: the atherosclerosis risk in communities (ARIC) study. Stroke. 2003;34(3):623–31.

    Article  Google Scholar 

  8. Tell GS, Crouse J, Furberg C. Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review. Stroke. 1988;19(4):423–30.

    Article  CAS  Google Scholar 

  9. Lv P, Jin H, Liu Y, Cui W, Peng Q, Liu R, et al. Comparison of risk factor between lacunar stroke and large artery atherosclerosis stroke: a cross-sectional study in China. PLoS One. 2016;11(3):e0149605.

    Article  Google Scholar 

  10. Arboix A, Font A, Garro C, Garcia-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry. 2007;78(12):1392–4.

    Article  CAS  Google Scholar 

  11. Nah H-W, Kang D-W, Kwon SU, Kim JS. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke. 2010;41(12):2822–7.

    Article  Google Scholar 

  12. Tang H, Wang Y, Cheng A, Wang A, Xu J, Zhang C, et al. Association between low-density lipoprotein cholesterol levels and proximal single subcortical infarction in comparison with distal single subcortical infarction. J Stroke Cerebrovasc Dis. 2020;29(11):105198.

    Article  Google Scholar 

  13. Yoon Y, Lee D, Kang D, Kwon S, Suh D, Bang O, et al. Stroke recurrence patterns are predicted by the subtypes and mechanisms of the past, non-cardiogenic stroke. Eur J Neurol. 2013;20(6):928–34.

    Article  CAS  Google Scholar 

  14. Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, et al. The Japan statin treatment against recurrent stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study. EBioMedicine. 2015;2(9):1071–8.

    Article  Google Scholar 

  15. Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, et al. Desirable low-density lipoprotein cholesterol levels for preventing stroke recurrence: a post hoc analysis of the J-STARS study (Japan statin treatment against recurrent stroke). Stroke. 2018;49(4):865–71.

    Article  CAS  Google Scholar 

  16. Kim JS, Nah H-W, Park SM, Kim S-K, Cho KH, Lee J, et al. Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43(12):3313–8.

    Article  CAS  Google Scholar 

  17. Lei C, Wu B, Liu M, Chen Y. Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(5):1112–7.

    Article  Google Scholar 

  18. Weber G. Delayed experimental atherosclerotic involvement of cerebral arteries in monkeys and rabbits (light, sem and tem observations). Pathol-Res Pract. 1985;180(4):353–5.

    Article  CAS  Google Scholar 

  19. Chung J-W, Cha J, Lee MJ, Yu I-W, Park M-S, Seo W-K, et al. Intensive statin treatment in acute ischaemic stroke patients with intracranial atherosclerosis: a high-resolution magnetic resonance imaging study (STAMINA-MRI study). J Neurol Neurosurg Psychiatry. 2020;91(2):204–11.

    Article  Google Scholar 

  20. Amarenco P, Hobeanu C, Labreuche J, Charles H, Giroud M, Meseguer E, et al. Carotid atherosclerosis evolution when targeting a low-density lipoprotein cholesterol concentration< 70 mg/dL after an ischemic stroke of atherosclerotic origin. Circulation. 2020;142(8):748–57.

    Article  CAS  Google Scholar 

  21. Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Bruckert E, et al. Benefit of targeting a LDL (low-density lipoprotein) cholesterol <70 mg/dL during 5 years after ischemic stroke. Stroke. 2020;51:1231–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong S. Kim .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kim, J.S. (2021). Practical Management of Dyslipidemia in Stroke Patients. In: Lee, SH., Kang, M.K. (eds) Stroke Revisited: Dyslipidemia in Stroke. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-16-3923-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-3923-4_14

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-3922-7

  • Online ISBN: 978-981-16-3923-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics